BLOOD 2023: Axicabtagene Ciloleucel Improves Survival in Relapsed/Refractory Large B-Cell Lymphoma
Benefit seen in various patient subgroups
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Benefit seen in various patient subgroups
Only registered members have full access to PracticeUpdate content.